Gilles Seydoux, PharmD
Co-Founder, Board Director & Chief Operating Officer
Gilles bring 30 years of US and international marketing and commercial leadership at GSK, Wyeth (now Pfizer), Procter & Gamble Pharmaceuticals, and Merck.
Since 2004, Gilles has held multiple roles at GSK, based in the US, including Global and US New Product Planning and Global Commercial Marketing Lead for several Diabetes and Rare Diseases products. From 2000-2004, at Wyeth, he was Vice President and Head of the Inflammation franchise, responsible for the global launch of Enbrel, a biologic drug which reached sales of over $8 billion in 2015, ranking as the third best-selling drug in the world. Gilles then became Vice-President, Commercial Operations for Europe and International. Prior to Wyeth, Gilles spent over 10 years in growing Marketing and General Management positions at Procter & Gamble Pharmaceuticals in Europe, Merck, and Gist-Brocades.
Gilles hold a Doctor of Pharmacy (PharmD) degree from Paris V University School of Pharmacy.
Gilles Seydoux is also a Board Director of Holding Carsey, a French company.